NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting - Seite 2

NuVasive's in-booth presentations at the NASS Annual Meeting include:

Wednesday, November 12, 2014

• 10:00 - 10:30 a.m. PT: XLIF Applications
• 12:00 - 1:00 p.m. PT: Anterior Column Realignment (ACR): Techniques to Restore Global Alignment
• 3:05 - 3:35 p.m. PT: XLIF Single Approach Surgery

Thursday, November 13, 2014

• 9:10 - 9:40 a.m. PT: Surgical Accuracy and Efficiency with Computer-Assisted Rod Bending
• 12:00 - 1:00 p.m. PT: Anterior Column Realignment (ACR): Techniques to Restore Global Alignment
• 3:10 - 3:40 p.m. PT: Single Approach Anterior Cervical Multi-Level Reconstruction

Friday, November 14, 2014

• 10:00 - 10:30 a.m. PT: The Better Way Back®: Getting XLIF Patients Back in the Game
• 12:00 -1:00 p.m. PT: The Better Way Back: How to Support Your Patients

To reference the NASS program, please visit: https://www.spine.org/Documents/Annual%20Meeting/FinalProgram2014.pdf

For more information about NASS please visit: https://www.spine.org/AM/Pages/NASS2014.aspx

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. The Company is the third largest player in the $8.7 billion global spine market. NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company's principal procedural solution is its Maximum Access Surgery, or MAS, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

NuVasive cautions you that statements included in this press release or made during the 2014 NASS Annual Meeting that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's minimally disruptive surgical products by spine surgeons, development and acceptance of new products or product enhancements, expansion of our network of sales representatives,  and the other risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Media Contacts:
Carol Cox
NuVasive, Inc.
858-638-5533
Email Contact

Calvin Allen
The Ruth Group
646-536-7002
Email Contact